Correspondence | Published:

CMV enhancer may not be suitable for tissue-specific enhancement of promoters in cancer gene therapy

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Gruh I, Wunderlich S, Winkler M, Schwanke K, Heinke J, Blömer U, et al. Human CMV immediate-early enhancer: a useful tool to enhance cell-type-specific expression from lentiviral vectors. J Gene Med. 2008;10:21–32.

  2. 2.

    Chen Q, Jia Z, Chen P, Wei Q, Zhang M, Chen J, et al. Study on the effect of human CMV early transcriptional enhancer on human CEA promoter. Chin J Cell Biol. 2010;32:726–32.

  3. 3.

    Ye J, Chen P, Jia Z, Li C, Chen L, Cao J. Improvement of human AFP promoter efficiency by CMV early enhancer. Chin J Cell Biol. 2013;35:486–93.

  4. 4.

    Argentin S, Nemer M, Drouin J, Scott GK, Kennedy BP, Davies PL. The gene for rat atrial natriuretic factor. J Biol Chem. 1985;260:4568–71.

  5. 5.

    Nemer M, Chamberland M, Sirois D, Argentin S, Drouin J, Dixon RA, et al. Gene structure of human cardiac hormone precursor, pronatriodilatin. Nature. 1984;312:654–6.

  6. 6.

    Argentin S, Ardati A, Tremblay S, Lihrmann I, Robitaille L, Drouin J, et al. Developmental stage-specific regulation of atrial natriuretic factor gene transcription in cardiac cells. Mol Cell Biol. 1994;14:777–90.

  7. 7.

    Sprenkle AB, Murray SF, Glembotski CC. Involvement of multiple cis elements in basal- and alpha-adrenergic agonist-inducible atrial natriuretic factor transcription. Circ Res. 1995;77:1060–9.

  8. 8.

    Mcbride K, Robitaille L, Tremblay S, Argentin S, Nemer M. fos/jun repression of cardiac-specific transcription in quiescent and growth-stimulated myocytes is targeted at a tissue-specific cis element. Mol Cell Biol. 1993;13:600–12.

  9. 9.

    LaPointe MC, Wu JP, Greenberg B, Gardner DG. Upstream sequences confer atrial-specific expression on the human atrial natriuretic factor gene. J Biol Chem. 1988;263:9075–8.

  10. 10.

    Zhu H, Garcia AV, Ross RS, Evans SM, Chien KR. A conserved 28-base-pair element (HF-1) in the rat cardiac myosin light-chain-2 gene confers cardiac-specific and alpha-adrenergic-inducible expression in cultured neonatal rat myocardial cells. Mol Cell Biol. 1991;11:2273–81.

  11. 11.

    Knowlton KU, Baracchini E, Ross RS, Harris AN, Henderson SA, Evans SM, et al. Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during alpha-adrenergic stimulation of neonatal rat ventricular cells. Identification of cis sequences within an embryonic and a constitutive contractile protein gene which mediate inducible expression. J Biol Chem. 1991;266:7759–66.

  12. 12.

    Bachurski CJ, Yang GH, Currier TA, Gronostajski RM, Hong D. Nuclear factor I/thyroid transcription factor 1 interactions modulate surfactant protein C transcription. Mol Cell Biol. 2003;23:9014–24.

  13. 13.

    Glasser SW, Burhans MS, Eszterhas SK, Bruno MD, Korfhagen TR. Human SP-C gene sequences that confer lung epithelium specific expression in transgenic mice. Am J Physiol Lung Cell Mol Physiol. 2000;278:L933–45.

  14. 14.

    Bachurski CJ, Kelly SE, Glasser SW, Currier TA. Nuclear factor I family members regulate the transcription of surfactant protein-C. J Biol Chem. 1997;272:32759–66.

  15. 15.

    Kelly SE, Bachurski CJ, Burhans MS, Glasser SW. Transcription of the lung-specific surfactant protein C gene is mediated by thyroid transcription factor 1. J Biol Chem. 1996;271:6881–8.

  16. 16.

    Chen CJ, Li LJ, Maruya A, Shively JE. In vitro and in vivo footprint analysis of the promoter of carcinoembryonic antigen in colon carcinoma cells: effects of interferon gamma treatment. Cancer Res. 1995;55:3873–82.

  17. 17.

    Boucher D, Cournoyer D, Stanners CP, Fuks A. Studies on the control of gene expression of the carcinoembryonic antigen family in human tissue. Cancer Res. 1989;49:847–52.

  18. 18.

    Tran R, Kashmiri SV, Kantor J, Greiner JW, Pestka S, Shively JE, et al. Correlation of DNA hypomethylation with expression of carcinoembryonic antigen in human colon carcinoma cells. Cancer Res. 1988;48:5674–9.

  19. 19.

    Guo X, Evans TR, Somanath S, Armesilla AL, Darling JL, Schatzlein A, et al. In vitro evaluation of cancer-specific NF-kappaB-CEA enhancer-promoter system for 5-fluorouracil prodrug gene therapy in colon cancer cell lines. Br J Cancer. 2007;97:745–54.

  20. 20.

    Li F, He J, Qiu Y, Liu Q, Xu X, Xiong X. Construction of eukaryotic expression vector containing HSV/TK double suicide genes for targeted therapy of lung cancer. China Oncol. 2007;17:37–40.

  21. 21.

    Liu T, Zhang G, Chen YH, Chen Y, Liu X, Peng J, et al. Tissue specific expression of suicide genes delivered by nanoparticles inhibits gastric carcinoma growth. Cancer Biol Ther. 2006;5:1683–90.

  22. 22.

    Nyati MK, Sreekumar A, Li S, Zhang M, Rynkiewicz SD, Chinnaiyan AM, et al. High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer. Cancer Res. 2002;62:2337–42.

  23. 23.

    Cao G, Kuriyama S, Cui L, Nagao S, Pan X, Toyokawa Y, et al. Analysis of the human carcinoembryonic antigen promoter core region in colorectal carcinoma-selective cytosine deaminase gene therapy. Cancer Gene Ther. 1999;6:572–80.

  24. 24.

    Qiao J, Doubrovin M, Sauter BV, Huang Y, Guo ZS, Balatoni J, et al. Tumor-specific transcriptional targeting of suicide gene therapy. Gene Ther. 2002;9:168–75.

  25. 25.

    Hauck W, Stanners CP. Transcriptional regulation of the carcinoembryonic antigene gene. Identification of regulatory elements and multiple nuclear factors. J Biol Chem. 1995;270:3602–10.

  26. 26.

    Richards CA, Austin EA, Huber BE. Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy. Hum Gene Ther. 1995;6:881–93.

  27. 27.

    Osaki T, Tanio Y, Tachibana I, Hosoe S, Kumagai T, Kawase I, et al. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res. 1994;54:5258–61.

  28. 28.

    Schrewe H, Thompson J, Bona M, Hefta LJ, Maruya A, Hassauer M, et al. Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression. Mol Cell Biol. 1990;10:2738–48.

  29. 29.

    Nakabayashi H, Koyama Y, Suzuki H, Li HM, Sakai M, Miura Y, et al. Functional mapping of tissue-specific elements of the human alpha-fetoprotein gene enhancer. Biochem Biophys Res Commun. 2004;318:773–85.

  30. 30.

    Watanabe K, Saito A, Tamaoki T. Cell-specific enhancer activity in a far upstream region of the human α-fetoprotein gene. J Biol Chem. 1987;262:4812–8.

  31. 31.

    Xiao Q, Kenessey A, Ojamaa K. Role of USF1 phosphorylation on cardiac α-myosin heavy chain promoter activity. Am J Physiol Heart Circ Physiol. 2002;283:H213–9.

  32. 32.

    Xiao Q, Ojamaa K. Regulation of cardiac alpha-myosin heavy chain gene transcription by a contractile-responsive E-box binding protein. J Mol Cell Cardiol. 1998;30:87–95.

  33. 33.

    Ghazal P, Lubon H, Fleckenstein B, Hennighausen L. Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer. Proc Natl Acad Sci USA. 1987;84:3658–62.

  34. 34.

    Boshart M, Weber F, Jahn G, Dorsch-Häsler K, Fleckenstein B, Schaffner W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell. 1985;41:521–30.

  35. 35.

    Ghazal P, Lubon H, Hennighausen L. Multiple sequence-specific transcription factors modulate cytomegalovirus enhancer activity in vitro. Mol Cell Biol. 1988;8:1809–11.

Download references

Acknowledgements

This work was supported by the Zhejiang Provincial Natural Science Foundation (No. LZ12H16003).

Author information

Correspondence to Jiang Cao.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark